We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+9.53%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$882M
AUM Growth
+$126M
Cap. Flow
+$66.7M
Cap. Flow %
7.55%
Top 10 Hldgs %
34.21%
Holding
2,922
New
175
Increased
1,422
Reduced
927
Closed
190

Sector Composition

Rank Sector Weight
1 Technology 12.49%
2 Healthcare 8%
3 Financials 7.49%
4 Consumer Staples 6.68%
5 Consumer Discretionary 5.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSGS icon
1626
Madison Square Garden
MSGS
$9.58B
$21.4K ﹤0.01%
117
-79
-40% -$12.4K
ASC icon
1627
Ardmore Shipping
ASC
$669M
$21.3K ﹤0.01%
1,475
+1,114
+309% +$14.8K
DFUV icon
1628
Dimensional US Marketwide Value ETF
DFUV
$15.5B
$21.3K ﹤0.01%
635
+3
+0.5% +$100
ENLC
1629
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$21.2K ﹤0.01%
1,726
UPBD icon
1630
Upbound Group
UPBD
$1.26B
$21.2K ﹤0.01%
941
+747
+385% +$16K
ENS icon
1631
EnerSys
ENS
$6.69B
$21.2K ﹤0.01%
287
-45
-14% -$3.14K
BBSI icon
1632
Barrett Business Services
BBSI
$1.01B
$21.2K ﹤0.01%
908
+128
+16% +$2.9K
INGN icon
1633
Inogen
INGN
$174M
$21.1K ﹤0.01%
1,072
+608
+131% +$13.1K
MRTX
1634
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$21.1K ﹤0.01%
466
-536
-53% -$34.7K
GSL icon
1635
Global Ship Lease
GSL
$1.57B
$21K ﹤0.01%
1,264
-482
-28% -$8.29K
WCC
1636
WESCO International
WCC
$16.1B
$21K ﹤0.01%
168
-45
-21% -$5.67K
USPH icon
1637
US Physical Therapy
USPH
$1.2B
$21K ﹤0.01%
259
+223
+619% +$18.7K
CBRL icon
1638
Cracker Barrel
CBRL
$1.2B
$20.8K ﹤0.01%
220
-150
-41% -$15.6K
RCM
1639
DELISTED
R1 RCM Inc. Common Stock
RCM
$20.7K ﹤0.01%
1,893
+1,872
+8,914% +$23.8K
PETS icon
1640
PetMed Express
PETS
$43M
$20.7K ﹤0.01%
1,168
+56
+5% +$1.11K
MED icon
1641
Medifast
MED
$108M
$20.6K ﹤0.01%
179
-28
-14% -$3.26K
LBRDK icon
1642
Liberty Broadband Class C
LBRDK
$4.72B
$20.6K ﹤0.01%
270
+71
+36% +$5.77K
MHK icon
1643
Mohawk Industries
MHK
$7.14B
$20.5K ﹤0.01%
201
+178
+774% +$17.5K
AGX icon
1644
Argan
AGX
$7.33B
$20.5K ﹤0.01%
557
-209
-27% -$7.35K
SLGN icon
1645
Silgan Holdings
SLGN
$5.07B
$20.5K ﹤0.01%
396
-372
-48% -$18.2K
HAE icon
1646
Haemonetics
HAE
$3.75B
$20.5K ﹤0.01%
261
+127
+95% +$10.2K
VECO icon
1647
Veeco
VECO
$2.79B
$20.4K ﹤0.01%
1,097
-1,341
-55% -$25.2K
LPSN icon
1648
LivePerson
LPSN
$22.9M
$20.4K ﹤0.01%
134
+60
+81% +$9.61K
DRH icon
1649
Diamondrock Hospitality Co
DRH
$2.67B
$20.3K ﹤0.01%
2,474
+1,299
+111% +$11.3K
BBDC icon
1650
Barings BDC
BBDC
$885M
$20.3K ﹤0.01%
2,485
+965
+63% +$8.35K

Similar funds

Quadrant Capital Group's Q4 2022 Portfolio in Review

As of Q4 2022, Quadrant Capital Group held 2,922 positions worth $882M, up 17% from $756M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Quadrant Capital Group deployed $66.7M of net new capital in Q4 2022, opening 175 new positions and adding to 1,422 existing holdings. Its largest new stake was Vanguard International High Dividend Yield ETF: 6,252 shares worth $372K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was JPMorgan Ultra-Short Income ETF, an estimated $7.2M trimmed.

  • Quadrant Capital Group's largest Q4 2022 buy was Vanguard International High Dividend Yield ETF: 6,252 shares worth $372K.
  • Quadrant Capital Group added most to Vanguard Short-Term Bond ETF in Q4 2022, an estimated $25.7M increase.
  • Quadrant Capital Group's biggest Q4 2022 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $7.2M.
  • Quadrant Capital Group fully exited Duke Realty Corp. in Q4 2022, selling an estimated $393K.
  • Quadrant Capital Group's ten largest holdings make up 34% of its $882M portfolio in Q4 2022.
  • Quadrant Capital Group opened 175 new positions and closed 190 in Q4 2022.
  • Quadrant Capital Group's portfolio value rose 17% quarter-over-quarter to $882M.

Based on Quadrant Capital Group's 13F filing for Q4 2022, filed 13 Feb 2023.